• Latest
Dr Ggoobi Visits NARO Anti-Tick Vaccine Facility Ahead of Commercial Production

Dr Ggoobi Visits NARO Anti-Tick Vaccine Facility Ahead of Commercial Production

7 hours ago
Museveni Rallies Tooro, Welcomes Request for Industrial Park in Fort Portal

Museveni Rallies Tooro, Welcomes Request for Industrial Park in Fort Portal

7 hours ago
Makerere, SoonPay Pen MoU to Drive Blockchain Innovation

Makerere, SoonPay Pen MoU to Drive Blockchain Innovation

7 hours ago
WE Finance Code to Boost Access to Finance for Women-Led Businesses

WE Finance Code to Boost Access to Finance for Women-Led Businesses

7 hours ago
Microfinance, SACCOs Key Drivers of National Wealth Creation – Kasaija

Microfinance, SACCOs Key Drivers of National Wealth Creation – Kasaija

7 hours ago
Prof. Nawangwe Wins African Educationist of the Year Award

Prof. Nawangwe Wins African Educationist of the Year Award

1 day ago
UK Lifts Warning Against Travel to Queen Elizabeth, Semuliki National Parks

UK Lifts Warning Against Travel to Queen Elizabeth, Semuliki National Parks

1 day ago
SoftPower News
Sunday, December 7, 2025
  • News
  • Tourism & Travel
  • Business
  • Lifestyle
    • Fashion
  • Regional
    • Kenya
    • Rwanda
    • Tanzania
    • Burundi
    • South Sudan
    • DR Congo
  • Defence & Security
  • Sport
  • Entertainment
  • More
    • Agriculture
    • Africa
    • Columnists
    • Education
    • Health
      • COVID-19
    • International News
    • News in Pictures
    • OpEd
    • Pearl Of Africa
    • People
    • Politics
    • Special Reports
    • Women
No Result
View All Result
  • News
  • Tourism & Travel
  • Business
  • Lifestyle
    • Fashion
  • Regional
    • Kenya
    • Rwanda
    • Tanzania
    • Burundi
    • South Sudan
    • DR Congo
  • Defence & Security
  • Sport
  • Entertainment
  • More
    • Agriculture
    • Africa
    • Columnists
    • Education
    • Health
      • COVID-19
    • International News
    • News in Pictures
    • OpEd
    • Pearl Of Africa
    • People
    • Politics
    • Special Reports
    • Women
No Result
View All Result
SoftPower News
No Result
View All Result
Home Agriculture

Dr Ggoobi Visits NARO Anti-Tick Vaccine Facility Ahead of Commercial Production

by Rogers Atukunda
December 7, 2025
Dr Ggoobi Visits NARO Anti-Tick Vaccine Facility Ahead of Commercial Production
20
VIEWS

 

Nakyesasa  – The Permanent Secretary and Secretary to the Treasury (PSST), Dr Ramathan Ggoobi, has visited the National Agricultural Research Organisation (NARO) Anti-Tick Vaccine facility at Nakyesasa to assess readiness and requirements ahead of its upcoming commercial production.

Related Stories

Museveni Rallies Tooro, Welcomes Request for Industrial Park in Fort Portal

Makerere, SoonPay Pen MoU to Drive Blockchain Innovation

WE Finance Code to Boost Access to Finance for Women-Led Businesses

Dr Ggoobi was guided through the state-of-the-art facility by NARO Director General Dr Yona Baguma, his Deputy Dr Swidiq Mugerwa, and other senior directors.

During the visit, the PSST commended NARO for its contribution to agricultural research and development, describing the organisation as “actively solving real-life problems facing our country.”

Highlighting the government’s economic vision, Dr Ggoobi noted that Uganda is on a mission to grow its economy tenfold. Under the Agricultural Transformation and Modernisation Strategy (ATMS), agro-industrialisation is projected to contribute USD 20 billion annually over the next 15 years, driving the country toward a USD 500 billion economy by 2040.

Accompanied by Acting Director of Debt & Cash Policy Maris Wanyera and Commissioner Paul Mwanja, Dr Ggoobi pledged continued support to NARO to complete the vaccine project, noting the institution’s proven accountability and results.

Dr Baguma expressed gratitude to H.E. President Yoweri Kaguta Museveni and the Ministry of Finance for backing the anti-tick vaccine research and the construction of the facility. He emphasised that NARO is now prepared to deliver the vaccine to the market, positioning Uganda as a global leader in cattle research.

The Nakyesasa facility is the largest of its kind in the world, with an annual production capacity of 42 million doses of the anti-tick vaccine, marking a major milestone in Uganda’s agro-industrial development.

Tags: Anti-tick vaccineDr Ramathan GgoobiNakyesasaNAROSoftPowerSoftPower NewsTop Uganda News

Recent Stories

Museveni Rallies Tooro, Welcomes Request for Industrial Park in Fort Portal

Makerere, SoonPay Pen MoU to Drive Blockchain Innovation

WE Finance Code to Boost Access to Finance for Women-Led Businesses

Dr Ggoobi Visits NARO Anti-Tick Vaccine Facility Ahead of Commercial Production

Microfinance, SACCOs Key Drivers of National Wealth Creation – Kasaija

Prof. Nawangwe Wins African Educationist of the Year Award

SoftPower News Logo

SoftPower News is a subsidiary of SoftPower Communications LLC, a Ugandan digital media group. Keep posted of the latest from Uganda and East Africa.
Plot 4B Malcolm X, Kololo
P.O Box 1497, Kampala - Uganda
Tel: +256-392-001-701
Email: info@softpower.ug

This news site is licenced by Uganda Communications Commission (UCC)

ADVERTISEMENT
  • News
  • Tourism & Travel
  • Business
  • Lifestyle
  • Regional
  • Defence & Security
  • Sport
  • Entertainment
  • More

© SoftPower News

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

error: Content is protected
No Result
View All Result
  • News
  • Tourism & Travel
  • Business
  • Lifestyle
    • Fashion
  • Regional
    • Kenya
    • Rwanda
    • Tanzania
    • Burundi
    • South Sudan
    • DR Congo
  • Defence & Security
  • Sport
  • Entertainment
  • More
    • Agriculture
    • Africa
    • Columnists
    • Education
    • Health
      • COVID-19
    • International News
    • News in Pictures
    • OpEd
    • Pearl Of Africa
    • People
    • Politics
    • Special Reports
    • Women

© SoftPower News

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?